US 5739002A
· De Francesco et al.
· 1998
[cited by applicant]
US 6005079A
· Casterman et al.
· 1999
[cited by applicant]
US 6348584B1
· Hodgson et al.
· 2002
[cited by applicant]
US 6673901B2
· Koide
· 2004
[cited by applicant]
US 6856914B1
· Pelech
· 2005
[cited by applicant]
US 6884870B2
· Hav et al.
· 2005
[cited by applicant]
US 8394604B2
· Liu et al.
· 2013
[cited by applicant]
US 20050271647A1
· Baltimore et al.
· 2005
[cited by applicant]
US 20080227750A1
· Dennis et al.
· 2008
[cited by applicant]
US 20130230863A1
· Tang et al.
· 2013
[cited by applicant]
US 20170315114A1
· Stein et al.
· 2017
[cited by applicant]
WO WO1994004678
· 1994
[cited by applicant]
WO WO1994025591
· 1994
[cited by applicant]
WO WO2014040129
· 2014
[cited by applicant]
WO WO2015017214
· 2015
[cited by applicant]
WO WO2015164594
· 2015
[cited by applicant]
WO WO2018069782
· 2018
[cited by applicant]
WO WO2019147478
· 2019
[cited by applicant]
Adams et al., “Overview and analysis of the polyprotein cleavage sites in the family Potyviridae,” Molecular Plant Pathology 2005, 6(4), 471-487.
[cited by applicant]
Angelici et al., “Synthetic Biology Platform for Sensing and Integrating Endogenous Transcriptional Inputs in Mammalian Cells,” Cell Reports 2016, 16, 2525-2537.
[cited by applicant]
Aronheim et al., “Membrane Targeting of the Nucleotide Exchange Factor Sos Is Sufficient for Activating the Ras Signaling Pathway,” Cell 1994, 78 ,949-961.
[cited by applicant]
Auslander et al., “Programmable single-cell mammalian biocomputers,” Nature 2012, 487, 123-127.
[cited by applicant]
Banaszynski et al., “A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules,” Cell 2006, 126, 995-1004.
[cited by applicant]
Barnea et al., “The genetic design of signaling cascades to record receptor activation,” PNAS 2008, 105(1), 64-69.
[cited by applicant]
Barrett et al., “Chimeric Antigen Receptor Therapy for Cancer,” Annual Review of Medicine 2014, 65, 333-347.
[cited by applicant]
Bartenschlager et al., “The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy,” Journal of Viral Hepatitis 1999, 6, 165-181.
[cited by applicant]
Basu et al., “A synthetic multicellular system for programmed pattern formation,” Nature 2005, 434, 1130-1134.
[cited by applicant]
Basu et al., “Spatiotemporal control of gene expression with pulse-generating networks,” PNAS 2004, 101(17), 6355-6360.
[cited by applicant]
Bintu et al., “Dynamics of epigenetic regulation at the single-cell level,” Science 2016, 351(6274), 720-724.
[cited by applicant]
Boerger et al., “Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types,” PNAS 1999, 96, 9867-9872.
[cited by applicant]
Bonnet et al., “Amplifying Genetic Logic Gates,” Science 2013, 340, 599-602.
[cited by applicant]
Budihardjo et al., “Biochemical Pathways of Caspase Activation During Apoptosis,” Annual Review of Cellular Development and Biology 1999, 15, 269-290.
[cited by applicant]
Butko et al., “Fluorescent and photo-oxidizing TimeSTAMP tags track protein fates in light and electron microscopy,” Nature Neuroscience 2012, 15(12), 1742-1751.
[cited by applicant]
Camacho-Soto et al., “Ligand-Gated Split-Kinases,” Journal of the American Chemical Society 2014, 136, 3995-4002.
[cited by applicant]
Camacho-Soto et al., “Small Molecule Gated Split-Tyrosine Phosphatases and Orthogonal Split-Tyrosine Kinases,” Journal of the American Chemical Society 2014, 136, 17078-17086.
[cited by applicant]
Carrington et al., “A viral cleavage site cassette: Identification of amino acid sequences required for tobacco etch virus polyprotein processing,” PNAS 1988, 85, 3391-3395.
[cited by applicant]
Chen et al., “Predicting PDZ domain-peptide interactions from primary sequences,” Nature Biotechnology 2008, 26(9), 1041-1045.
[cited by applicant]
Choi et al., “Selective viral vector transduction of ErbB4 expressing cortical interneurons in vivo with a viral receptor-ligand bridge protein,” PNAS 2010, 107(38), 16703-16708.
[cited by applicant]
Chung et al., “Tunable and reversible drug control of protein production via a self-excising degron,” Nature Chemical Biology 2015, 11, 713-720.
[cited by applicant]
Corrected Notice of Allowance dated Aug. 31, 2022 in U.S. Appl. No. 16/556,063.
[cited by applicant]
Corrected Notice of Allowance dated Jun. 29, 2022 in U.S. Appl. No. 16/555,604.
[cited by applicant]
Cox et al., “Drugging the undruggable Ras: mission possible?,” Nature Reviews Drug Discovery 2014, 13(11), 828-851.
[cited by applicant]
Dagliyan et al., “Computational design of chemogenetic and optogenetic split proteins,” Nature Communications, 9(4042), 1-8, (2018).
[cited by applicant]
Daringer et al., “Modular Extracellular Sensor Architecture for Engineering Mammalian Cell-based Devices,” ACS Synthetic Biology 2014, 3, 892-902.
[cited by applicant]
De Felipe et al., “Targeting of Proteins Derived from Self-Processing Polyproteins Containing Multiple Signal Sequences,” Traffic 2004, 5, 616-626.
[cited by applicant]
De Felipe, “Skipping the co-expression problem: the new 2A “Chysel” technology,” Genetic Vaccines and Therapy 2004, 2(13).
[cited by applicant]
Dissing et al., “Autoproteolysis and feedback in a protease cascade directing
[cited by applicant]
Downward, “Targeting RAS Signaling Pathways in Cancer Therapy,” Nature Publishing Group 2003, 3, 11-22.
[cited by applicant]
Dueber et al., “Reprogramming Control of an Allosteric Signaling Switch Through Modular Recombination,” Science 2003, 301, 1904-1908.
[cited by applicant]
Elowitz et al., “A synthetic oscillatory network of transcriptional regulators,” Nature 2000, 403, 335- 338.
[cited by applicant]
Extended European Search Report dated Jun. 15, 2022 in European Patent Application No. 19854896.8.
[cited by applicant]
Fernandez-Rodriguez et al., “Post-translational control of genetic circuits using Potyvirus proteases,” Nucleic Acids Research 2016, 44(13), 6493-6502.
[cited by applicant]
Ferrell et al., “Ultrasensitivity Part II: Multisite phosphorylation, stoichiometric inhibitors, and positive feedback,” Trends in Biochemical Sciences 2014, 39(11), 556-569.
[cited by applicant]
Fink et al., “Design of fast proteolysis-based signaling and logic circuits in mammalian cells,” Nature Chemical Biology 2018, 15, 115-122.
[cited by applicant]
Gao et al., “Programmable protein circuits in living cells,” Science 2018, 361, 1252-1258.
[cited by applicant]
Gardner et al., “Construction of a genetic toggle switch in Escherichia coli,” Nature, 403, 339-342.
[cited by applicant]
Ghabrial et al., “Molecular genetic analyses of the soybean mosaic virus Nla proteinase,” Journal of General Virology 1990, 71, 1921-1927.
[cited by applicant]
Ghosh et al., “Antiparallel Leucine Zipper-Directed Protein Reassembly: Application to the Green Fluorescent Protein,” Journal of the American Chemical Society 2000, 122, 5658-5659.
[cited by applicant]
Gramespacher et al., “Intein Zymogens: Conditional Assembly and Splicing of Split Inteins via Targeted Proteolysis,” Journal of the American Chemical Society 2017, 139, 8074-8077.
[cited by applicant]
Gray et al., “Activation of Specific Apoptotic Caspases with an Engineered Small Molecule-Activated Protease,” Cell 2010, 142(4), 637-646.
[cited by applicant]
Greber et al., “An engineered mammalian band-pass network,” Nucleic Acids Research 2010, 38(18), e174.
[cited by applicant]
Griesbeck et al., “Reducing the Environmental Sensitivity of Yellow Fluorescent Protein,” The Journal of Biological Chemistry 2001, 276(31), 29188-29194. doi:10.1074/jbc.M102815200.
[cited by applicant]
Hancock et al., “A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins,” The EMBO Journal 1991, 10(13), 4033-4039.
[cited by applicant]
Hart et al., “The Utility of Paradoxical Components in Biological Circuits,” Molecular Cell 2013, 49, 213-221.
[cited by applicant]
Herrmann et al., “Quantitative Analysis of the Complex between p21ras and the Ras-binding Domain of the Human Raf-1 Protein Kinase,” Journal of Biological Chemistry 1995, 270(7), 2901-2905.
[cited by applicant]
Holt, Brandon Alexander, and Gabriel A. Kwong. “Protease circuits for processing biological information.”
[cited by applicant]
Howard et al., “Redirecting tyrosine kinase signaling to an apoptotic caspase pathway through chimeric adaptor proteins,” PNAS 2003, 100(20), 11267-11272.
[cited by applicant]
International Search Report and Written Opinion dated Aug. 12, 2019 in PCT Patent Application PCT/US2019/014078.
[cited by applicant]
International Search Report and Written Opinion dated Dec. 19, 2019 in PCT Patent Application PCT/US2019/048914.
[cited by applicant]
International Search Report and Written Opinion dated May 7, 2020 in PCT Patent Application PCT/US2020/012928.
[cited by applicant]
Iwamoto et al., “A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System,” Chemistry & Biology 2010, 17, 981-988.
[cited by applicant]
Jacobs et al., “StaPLs: versatile genetically encoded modules for engineering drug-inducible proteins,” Nature Methods 2018, 15(7), 523-526.
[cited by applicant]
Khalil et al., “A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions,” Cell 2012, 150, 647-658.
[cited by applicant]
Kim et al., “Time-gated detection of protein-protein interactions with transcriptional readout,” eLife 2017, 6, e30233.
[cited by applicant]
Kipniss et al., “Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system,” Nature Communications 2017, 8, 2212.
[cited by applicant]
Koch-Nolte et al., “Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo,” The FASEB Journal 2007, 21, 3490-3498.
[cited by applicant]
Koh et al., “An Internal Ribosome Entry Site (IRES) Mutant Library for Tuning Expression Level of Multiple Genes in Mammalian Cells,” PLOS One 2013, 8(12), e82100.
[cited by applicant]
Kojima et al., “Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic intervention,” Advanced Drug Delivery Reviews 2016, 105, 66-76.
[cited by applicant]
Lichty et al., “Vesicular stomatitis virus: re-inventing the bullet,” Trends in Molecular Medicine 2004, 10(5), 210-216.
[cited by applicant]
Lienert et al., “Synthetic biology in mammalian cells: Next generation research tools and therapeutics,” Nature Reviews of Molecular Cell Biology 2014, 15(2), 95-107.
[cited by applicant]
Lohmueller et al., “A tunable zinc finger-based framework for Boolean logic computation in mammalian cells,” Nucleic Acids Research 2012, 40(11), 5180-5187.
[cited by applicant]
Lonzaric et al., “Design and applications of synthetic information processing circuits in mammalian cells,” Synthetic Biology 2018, 2, 1-34.
[cited by applicant]
Ma et al., “Defining Network Topologies that Can Achieve Biochemical Adaptation,” Cell 2009, 138, 760-773.
[cited by applicant]
Marchisio et al., “Computational design of synthetic gene circuits with composable parts,” Bioninformatics 2008, 24(17), 1903-1910.
[cited by applicant]
Morsut et al., “Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors,” Cell 2016, 164(4), 780-791.
[cited by applicant]
Nakanishi et al., Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine, Current Gene Therapy 2012, 12, 410-416.
[cited by applicant]
Nallamsetty et al., “Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro,” Protein Expression and Purification 2004, 38, 108-115.
[cited by applicant]
Nelson, “Antibody fragments,” mAbs 2010, 2(1), 77-83.
[cited by applicant]
Nielsen et al., “Genetic circuit design automation,” Science 2016, 352(6281), aac7341.
[cited by applicant]
Nissim et al., “A tunable dual-promoter integrator for targeting of cancer cells,” Molecular Systems Biology 2010, 6(444), 1-9.
[cited by applicant]
Non-final Office Action dated Apr. 18, 2022 in U.S. Appl. No. 16/556,063.
[cited by applicant]
Non-final Office Action dated Jun. 14, 2022 in U.S. Appl. No. 16/738,664.
[cited by applicant]
Non-final Office Action dated Jun. 28, 2023 in U.S. Appl. No. 17/157,880.
[cited by applicant]
Notice of Allowance dated Aug. 24, 2022 in U.S. Appl. No. 16/556,063.
[cited by applicant]
Notice of Allowance dated Dec. 20, 2023 in U.S. Appl. No. 17/157,880.
[cited by applicant]
Notice of Allowance dated Jan. 26, 2023 in U.S. Appl. No. 16/738,664.
[cited by applicant]
Notice of Allowance dated May 18, 2022 in U.S. Appl. No. 16/555,604.
[cited by applicant]
Notice of Allowance Dated Nov. 22, 2023 in U.S. Appl. No. 17/935,024.
[cited by applicant]
Notice of Allowance Dated Sep. 16, 2020 in U.S. Appl. No. 16/250,314.
[cited by applicant]
Oliveira et al., “An Improved Ras Sensor for Highly Sensitive and Quantitative FRET-FLIM Imaging,” PLOS One 2013, 8(1), e52874.
[cited by applicant]
Park et al., “Rewiring MAP Kinase Pathways Using Alternative Scaffold Assembly Mechanisms,” Science 2003, 299, 1061-1064.
[cited by applicant]
Partial European Search Report dated Nov. 19, 2021 in European Patent Application 19743690.0.
[cited by applicant]
Porcher et al., “The Bicoid Morphogen System,” Current Biology 2010, 20(5), R249-R254.
[cited by applicant]
Pu et al., “Evolution of a split RNA polymerase as a versatile biosensor platform,” Nature Chemical Biology 2017, 13(4), 432-438.
[cited by applicant]
Reinke et al., “A synthetic coiled-coil interactome provides heterospecific modules for molecular engineering,” Journal of the American Chemical Society 2010, 132(17), 6025-6031.
[cited by applicant]
Restriction Requirement Dated Dec. 7, 2021 in U.S. Appl. No. 16/738,664.
[cited by applicant]
Restriction Requirement Dated Dec. 9, 2019 in U.S. Appl. No. 16/250,314.
[cited by applicant]
Restriction Requirement Dated Feb. 24, 2023 in U.S. Appl. No. 17/157,880.
[cited by applicant]
Restriction Requirement Dated Sep. 28, 2021 in U.S. Appl. No. 16/556,063.
[cited by applicant]
Riechmann et al., “Single domain antibodies: comparison of camel VH and camelised human VH domains,” Journal of Immunological Methods 1999, 231, 25-38.
[cited by applicant]
Rinaudo et al., “A universal RNAi-based logic evaluator that operates in mammalian cells,” Nature Biotechnology 2007, 1-6.
[cited by applicant]
Roquet et al., “Synthetic recombinase-based state machines in living cells,” Science 2016, 353(6297), aad8559.
[cited by applicant]
Rossi et al., “Monitoring protein-protein interactions in intact eukaryotic cells by b-galactosidase complementation,” PNAS 1997, 94, 8405-8410.
[cited by applicant]
Roybal et al., “Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits,” Cell 2016, 164, 770-779.
[cited by applicant]
Russell et al., “Oncolytic Virotherapy,” Nature Biotechnology 2012, 30(7).
[cited by applicant]
Schnell et al., “Infectious rabies viruses from cloned cDNA,” The EMBO Journal 1994, 13(18), 4195-4203.
[cited by applicant]
Schwanhausser et al. “Global quantification of mammalian gene expression control” Nature 2011, 473, 337-342.
[cited by applicant]
Shekhawat et al., “An Autoinhibited Coiled-Coil Design Strategy for Split-Protein Protease Sensors,” J. Am. Chem Soc. 2009, 131, 15284-15290.
[cited by applicant]
Snitkovsky et al., “A TVA-Single-Chain Antibody Fusion Protein Mediates Specific Targeting of a Subgroup A Avian Leukosis Virus Vector to Cells Expressing a Tumor-Specific Form of Epidermal Growth Factor Receptor,” Jour…
[cited by applicant]
Stein et al., “Protease-based synthetic sensing and signal amplification,” PNAS 2014, 1-6.
[cited by applicant]
Stein et al., “Synthetic protein switches: design principles and applications,” Trends in Biotechnology 2015, 33(2), 101-110.
[cited by applicant]
Stein et al., “Ultrasensitive Scaffold-Dependent Protease Sensors with Large Dynamic Range,” ACS Synthetic Biology 2017, 6, 1337-1342.
[cited by applicant]
Stevens et al., “Design of a Split Intein with Exceptional Protein Splicing Activity,” Journal of the American Chemical Society 2016, 138, 2162-2165.
[cited by applicant]
Stricker et al. “A fast, robust and tunable synthetic gene oscillator,” Nature 2008, 456, 516-520.
[cited by applicant]
Supplementary Partial European Search Report dated Nov. 19, 2021 in European Application No. 19743690.0.
[cited by applicant]
Szymczak et al., “Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector,” Nature Biotechnology 2004, 22, 589-594.
[cited by applicant]
Tang et al., “Detection and manipulation of live antigen-expressing cells using conditionally stable nanobodies,” eLIFE 2016, 5, 1-27.
[cited by applicant]
Taremi et al., “Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease,” Protein Science 1998, 7, 2143-2149.
[cited by applicant]
Taxis et al., “Efficient protein depletion by genetically controlled deprotection of a dormant N-degron,” Molecular Systems Biology 2009, 5(267), 1-7.
[cited by applicant]
To et al., “Rationally designed fluorogenic protease reporter visualizes spatiotemporal dynamics of apoptosis in vivo,” PNAS 2015, 112(11), 3338-3343.
[cited by applicant]
Tozser et al., “Comparison of the substrate specificity of two potyvirus proteases,” The FEBS Journal 2005, 272, 514-523.
[cited by applicant]
Truong et al., “Development of an intein-mediated split-Cas9 system for gene therapy,” Nucleic Acids Research 2015, 43(13), 6450-6458.
[cited by applicant]
Varshavsky, “The N-end rule: Functions, mysteries, uses,” PNAS 1996, 93, 12142-12149.
[cited by applicant]
Waugh, “An overview of enzymatic reagents for the removal of affinity tags,” Protein Expression and Purification 2011.
[cited by applicant]
Wehr et al., “Monitoring regulated protein-protein interactions using split TEV,” Nature Methods 2006, 3(12), 985-993.
[cited by applicant]
Weinberg et al., “Large-scale design of robust genetic circuits with multiple inputs and outputs for mammalian cells,” Nature Biotechnology 2017, 35(5), 453-462.
[cited by applicant]
Weinheimer et al., “Autoproteolysis of Herpes Simplex Virus Type 1 Protease Releases an Active Catalytic Domain Found in Intermediate Capsid Particles,” Journal of Virology 1993, 67(10), 5813-5822.
[cited by applicant]
Wikstrand et al., “The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target,” Journal of NeuroVirology 1998, 4, 148-158.
[cited by applicant]
Wroblewska et al., “Mammalian synthetic circuits with RNA binding proteins delivered by RNA,” Nature Biotechnology 2015, 33(8), 839-841.
[cited by applicant]
Wu, Yiqian, and Yingxiao Wang. “Protein circuits reprogram cells.” Nature chemical biology 15.2 (2019): 96-97.
[cited by applicant]
Xie et al., “Multi-Input RNAi-Based Logic Circuit for Identification of Specific Cancer Cells,” Science 2011, 333, 1307-1311.
[cited by applicant]
Yasuda et al., “Supersensitive Ras activation in dendrites and spines revealed by two-photon fluorescence lifetime imaging,” Nature Neuroscience 2006, 9(2), 283-291.
[cited by applicant]
Yeh et al., “Rewiring cellular morphology pathways with synthetic guanine nucleotide exchange factors,” Nature 2007, 447, 596-600.
[cited by applicant]
Zetche et al., “A Split Cas9 Architecture for Inducible Genome Editing and Transcription Modulation,” Nature Biotechnology 2015, 33(2), 139-142.
[cited by applicant]